HealthCare Global Enterprises (HCG), jo cancer care mein ek bada naam hai, ne Bengaluru ke Hebbal district mein ek naya 132 beds wala facility shuru kiya hai. Is bade expansion ke liye company ne lagbhag ₹129 crore kharch kiye hain.
Cutting-edge Technology
Is naye center se Bengaluru mein HCG ki capacity kaafi badh gayi hai, aur ab city mein unke total 3 hospitals ho gaye hain. Yeh facility advanced diagnostic aur treatment technology se suposs hai, jaise ki ek MRI scanner jo linear accelerator ke saath integrated hai taaki cancer therapy ko aur precise banaya ja sake. HCG ke founder, B S Ajaikumar ne bhi kaha ki cancer care mein data aur technology ka role bahut important ho raha hai, yahan tak ki advanced cases ko manage karne ke liye bhi.
Strategic Move
Yeh launch pichle saal private equity firm KKR dwara HCG mein 54% stake kharidne ke baad aaya hai, jismein ₹3,466 crore lage the. Filhaal, HCG desh bhar mein 25 centers par lagbhag 2,500 beds manage karta hai, aur founder Ajaikumar aur unki family ka abhi bhi 10% holding hai.
Acquisition Talks
News yeh bhi aa rahi hai ki HCG, Siemens Healthineers ke controlled American Oncology ko acquire karne ki baatcheet kar raha hai, kyunki German company apna hissa bechna chahti hai. Is naye Hebbal facility mein 5 robotic-assisted operation theaters, 19 chemotherapy daycare beds, 14 premium treatment bays, aur 15 beds ka ICU bhi hai. Yahan endoscopy, mammography, advanced labs aur histopathology jaisi comprehensive services bhi provide ki jaayengi.
HCG ke chief executive, Manish Mattoo ne bataya ki yeh facility patient-centric care, multidisciplinary expertise aur latest technology dene ke liye committed hai.
